FOXA2 and colorectal carcinoma: Survival information from the online KM‐Plotter database for relapse‐free‐survival (RFS) showed that CRC patients with high FOXA2 levels experienced markedly worse clinical outcomes (Figure 1D), while no significant difference was detected in the changes of overall survival rates among CRC patients based on TCGA database (Figure S1C and Table S3, Supporting Information).